JP2009501001A5 - - Google Patents

Download PDF

Info

Publication number
JP2009501001A5
JP2009501001A5 JP2008514849A JP2008514849A JP2009501001A5 JP 2009501001 A5 JP2009501001 A5 JP 2009501001A5 JP 2008514849 A JP2008514849 A JP 2008514849A JP 2008514849 A JP2008514849 A JP 2008514849A JP 2009501001 A5 JP2009501001 A5 JP 2009501001A5
Authority
JP
Japan
Prior art keywords
virus
capsid fusion
fusion peptide
particle
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008514849A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009501001A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/021262 external-priority patent/WO2007053188A2/en
Publication of JP2009501001A publication Critical patent/JP2009501001A/ja
Publication of JP2009501001A5 publication Critical patent/JP2009501001A5/ja
Pending legal-status Critical Current

Links

JP2008514849A 2005-06-01 2006-06-01 多価ウイルス様粒子の製造 Pending JP2009501001A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68654105P 2005-06-01 2005-06-01
PCT/US2006/021262 WO2007053188A2 (en) 2005-06-01 2006-06-01 Production of multivalent virus like particles

Publications (2)

Publication Number Publication Date
JP2009501001A JP2009501001A (ja) 2009-01-15
JP2009501001A5 true JP2009501001A5 (cg-RX-API-DMAC7.html) 2009-07-09

Family

ID=38006346

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008514849A Pending JP2009501001A (ja) 2005-06-01 2006-06-01 多価ウイルス様粒子の製造

Country Status (9)

Country Link
US (1) US20070041999A1 (cg-RX-API-DMAC7.html)
EP (1) EP1885394A4 (cg-RX-API-DMAC7.html)
JP (1) JP2009501001A (cg-RX-API-DMAC7.html)
KR (1) KR20080018176A (cg-RX-API-DMAC7.html)
CN (1) CN101287489A (cg-RX-API-DMAC7.html)
AU (1) AU2006309286A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0611336A2 (cg-RX-API-DMAC7.html)
CA (1) CA2608515A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007053188A2 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100021391A1 (en) * 2006-07-14 2010-01-28 Montana State University Novel nanoparticles for biofilm targeting
EP2601969B1 (en) 2006-09-29 2016-03-30 Takeda Vaccines, Inc. Norovirus vaccine formulations
WO2009033004A1 (en) * 2007-09-07 2009-03-12 Montana State University Protein cages and their uses
US20100266636A1 (en) 2007-09-18 2010-10-21 Ligocyte Pharmaceuticals, Inc. Method of conferring a protective immune response to norovirus
CN104740624B (zh) 2007-09-18 2018-04-24 武田疫苗股份有限公司 赋予针对诺如病毒的保护性免疫应答的疫苗
US9566323B2 (en) * 2009-06-19 2017-02-14 Eyegene Inc. Vaccine for cervical cancer
CA2804501C (en) 2010-07-06 2021-01-26 Novartis Ag Noro virus derived immunogenic compositions and methods
PH12014500093A1 (en) 2011-07-11 2014-03-17 Takeda Vaccines Inc Parenteral norovirus vaccine formulations
PL3597757T3 (pl) * 2012-05-11 2021-05-31 Medicago Inc. Wytwarzanie cząstek podobnych do rotawirusów w roślinach
US10086062B2 (en) 2012-07-05 2018-10-02 Ohio State Innovation Foundation Infectious pancreatic necrosis virus (IPNV) vaccine compositions
WO2014008475A2 (en) 2012-07-05 2014-01-09 The Ohio State University Compositions and methods related to viral vaccines
EP3089755A1 (en) * 2014-01-03 2016-11-09 Fundacion Biofisica Bizkaia VLPs, METHODS FOR THEIR OBTENTION AND APPLICATIONS THEREOF
WO2015191546A2 (en) * 2014-06-10 2015-12-17 The Board Of Regents Of The University Of Texas System Adp-ribose detection reagents
CN105018463A (zh) * 2015-06-05 2015-11-04 北京百迈客生物科技有限公司 一种用于次生代谢物含量高的植物组织的dna提取方法
KR101830792B1 (ko) * 2016-01-27 2018-02-21 건국대학교 산학협력단 항균 펩타이드를 포함하는 불용성 융합단백질 및 이를 이용한 항균 펩타이드의 제조 방법
CN108558990A (zh) * 2018-01-05 2018-09-21 山东省科学院生态研究所 肿瘤靶向肽f3修饰的豇豆褪绿斑驳病毒样颗粒的构建、表达及其应用
US20230038487A1 (en) * 2019-11-25 2023-02-09 The Regents Of The University Of California Modified viral therapeutics and uses thereof
US20250108108A1 (en) * 2020-04-14 2025-04-03 The Regents Of The University Of California Hybrid flu-coronavirus vaccine
CN117098553A (zh) 2020-11-11 2023-11-21 加州理工学院 多价载体和相关疫苗组合物
CN115747170B (zh) * 2022-08-29 2023-08-04 四川大学 一种豇豆褪绿斑驳病毒-多肽复合物及其在骨质疏松治疗中的应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511503A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
GB9108386D0 (en) * 1991-04-19 1991-06-05 Agricultural Genetics Co Modified plant viruses as vectors
GB9414118D0 (en) * 1994-07-13 1994-08-31 Axis Genetics Ltd Modified plant viruses as vectors of heterologous peptides
US6042832A (en) 1996-08-28 2000-03-28 Thomas Jefferson University Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins
AU742409B2 (en) * 1997-09-05 2002-01-03 Medimmune, Llc In vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPs)
US6171591B1 (en) * 1997-12-08 2001-01-09 Pentamer Pharmaceuticals, Inc. Recombinant nodavirus compositions and methods
KR100312456B1 (ko) * 1999-03-13 2001-11-03 윤덕용 슈도모나스 플루오레슨스 유래의 외래단백질 분비촉진유전자
US6514948B1 (en) * 1999-07-02 2003-02-04 The Regents Of The University Of California Method for enhancing an immune response
US7135282B1 (en) * 1999-10-14 2006-11-14 The Dow Chemical Company Viral particles with exogenous internal epitopes
GB9924352D0 (en) * 1999-10-14 1999-12-15 Hellendoorn Koen Methods,compositions and applications relating to the generation of novel plant viral particles
US6552006B2 (en) * 2000-01-31 2003-04-22 The Regents Of The University Of California Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen
US20030050268A1 (en) * 2001-03-29 2003-03-13 Krieg Arthur M. Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases
WO2003068804A2 (en) * 2002-02-14 2003-08-21 Novavax, Inc. Novel insect cell line
WO2003087129A2 (en) * 2002-04-08 2003-10-23 Siga Technologies, Inc. Immunogenic peptides, and method of identifying same
JP2006507800A (ja) * 2002-06-07 2006-03-09 ラージ・スケール・バイオロジー・コーポレイション 可撓性ワクチンアセンブリおよびワクチン送達プラットフォーム
MXPA05000287A (es) * 2002-07-05 2005-09-08 Leclerc Denis Particula viral adyuvante.
WO2005005614A2 (en) 2003-07-03 2005-01-20 Pecos Labs, Inc. Combined b-cell and t-cell epitopes on vlp for improved vaccines
AU2004255470B2 (en) * 2003-07-10 2010-08-19 Cytos Biotechnology Ag Packaged virus-like particles
CA2547511A1 (en) * 2003-12-01 2005-07-28 Dow Global Technolgies Inc. Recombinant icosahedral virus like particle production in pseudomonads

Similar Documents

Publication Publication Date Title
Kanekiyo et al. New vaccine design and delivery technologies
TWI688652B (zh) 作為對抗腸病毒感染之免疫原的病毒顆粒及其製造
Yan et al. The application of virus-like particles as vaccines and biological vehicles
Pushko et al. Development of virus-like particle technology from small highly symmetric to large complex virus-like particle structures
Naskalska et al. Virus like particles as immunogens and universal nanocarriers
Sarkar et al. Virus like particles-A recent advancement in vaccine development
Kalnciema et al. Potato virus Y-like particles as a new carrier for the presentation of foreign protein stretches
Betenbaugh et al. Nucleocapsid-and virus-like particles assemble in cells infected with recombinant baculoviruses or vaccinia viruses expressing the M and the S segments of Hantaan virus
WO2005055957A3 (en) Influenza immunogen and vaccine
JP2022516088A5 (cg-RX-API-DMAC7.html)
WO2000032227A3 (en) Ordered molecular presentation of antigens, method of preparation and use
WO2008115199A3 (en) Chimeric virus vaccines
CA2405438A1 (en) Hepatitis b core antigen fusion proteins
JP2009516529A5 (cg-RX-API-DMAC7.html)
JP2007512842A5 (cg-RX-API-DMAC7.html)
WO2007019247A3 (en) Virus-like particles as vaccines for paramyxovirus
JP2017515508A5 (cg-RX-API-DMAC7.html)
JP2006504644A5 (cg-RX-API-DMAC7.html)
CN104480143A (zh) 一种表达脊髓灰质炎病毒样颗粒蛋白的载体及脊髓灰质炎病毒样颗粒的制备方法
CN104611358B (zh) 一种在大肠杆菌中制备诺如病毒病毒样颗粒的方法
JP2025169275A5 (cg-RX-API-DMAC7.html)
WO2007053188A3 (en) Production of multivalent virus like particles
JP2010508857A5 (cg-RX-API-DMAC7.html)
WO2002000169A3 (en) Production of vaccines using transgenic plants
Jeoung et al. Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig